Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changji'an Capsules in Diarrhea-Predominant Irritable Bowel Syndrome
NCT07610434Phase 3Not yet recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- May 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 3 trial of Changji'an Capsule in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Beijing Hospital of Traditional Chinese Medicine. Planned start May 2026; status: not yet recruiting.
02
Drugs
Changji'an Capsule
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT07610434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07610434.